At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
For October’s installment of Editors’ Picks, the AACR journal editors have selected studies that feature results from two phase...
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete,...
Unlike cancer incidence rates overall, which are decreasing in the United States, the incidence rate of liver cancer has been increasing...
Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, received the 2020 Nobel Prize in Chemistry last Wednesday, marking the third consecutive year in...
Immune checkpoint inhibition is a form of cancer immunotherapy that works by releasing the “brakes” on the immune system, thereby increasing...
As the coronavirus pandemic took root in the United States, many hospitals and cancer centers temporarily suspended treatments and...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...
Friday morning, the AACR’s virtual conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved opened against a...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
Prostate cancer is the most common non-skin cancer in men, and is the second leading cause of cancer-related death among men in the United States. Although there...